The pharmacokinetic-nephrotoxicity relationships of CMS and CMS-E2 from the perspective of plasma and kidney drug concentrations in rats
Abstract Nephrotoxicity has seriously affected the clinical application of colistin methanesulphonate (CMS). Colistin B methanesulphonate (CMS-E2) is a novel polymyxin developed and aimed to have lower nephrotoxicity. This study aimed to investigate the relationships between pharmacokinetics (PK) an...
Saved in:
| Main Authors: | Chenxue Guo, Lin Xi, Xingyi Qu, Zhiwei Huang, Size Li, Wanzhen Li, Xiaofen Liu, Jing Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-96407-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study
by: Khalid Al Sulaiman, et al.
Published: (2022-12-01) -
Colistin-induced nephrotoxicity and the role of N-acetylcysteine: a retrospective cohort study
by: Ilkay Bozkurt, et al.
Published: (2017-12-01) -
Factors Associated with Successful Treatment of Carbapenem-Resistant Gram-Negative Bacilli Infections Using Intravenous Colistin Sulfate in China: A Real-World Retrospective Study
by: Gao W, et al.
Published: (2025-04-01) -
Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy
by: Ayse Serra Ozel, et al.
Published: (2019-10-01) -
Pharmacokinetics of colistin in patients with multi-drug resistant Gram-negative bacterial infections
by: Harivenkatesh Natarajan, et al.
Published: (2024-12-01)